Corporate Key Facts


  1. Founded as a spin-off biotech company of the leading scientific information provider Prous Science (acquired by Thomson Reuters in 2007)
  2. Headquarters and laboratories located in Barcelona and International Development Offices in US & Japan (planned 2013)
  3. Strong leadership team with track record in industry and academia
  4. Proprietary chemical libraries and proven drug discovery platform (Symmetry®) based on unique in silico technologies
  5. Focused on four main discovery programs: cancer, pain, diabetes and neurodegenerative diseases with ongoing preclinical projects
  6. Active partnerships with leading academic and regulatory institutions including two five year agreements with the US Food and Drug Administration (FDA)
  7. Ongoing Drug Discovery Partnerships with Pharma and Biotech organizations
  8. Strong private financial backing to advance internal research programs and investment in emerging opportunities
  9. Research partially funded by publically supported CDTI grants (Center for Industrial Technological Development - Ministry for Science and Innovation)
  10. Associated with The Barcelona Science Park